/Abbott%20Laboratories%20logo-by%20360b%20via%20Shutterstock.jpg)
Abbott Laboratories (ABT), with a market cap of $178 billion, manufactures and sells a wide range of healthcare products across pharmaceuticals, diagnostics, nutrition, and medical devices. The North Chicago, Illinois-based company is slated to announce its fiscal Q2 earnings results before the market opens on Thursday, July 18.
Ahead of the event, analysts are expecting ABT to report a profit of $1.10 per share, up 1.9% from $1.08 per share in the year-ago quarter. The company has met or surpassed Wall Street's bottom-line estimates in the past four quarterly reports. Abbott surpassed the consensus EPS estimate by 2.1% in the most recent quarter, driven by robust sales in its medical devices segment, particularly its glucose-monitoring product.
